Jpmorgan Chase & CO Anika Therapeutics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 26,581 shares of ANIK stock, worth $651,766. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,581
Previous 27,375
2.9%
Holding current value
$651,766
Previous $695,000
3.17%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ANIK
# of Institutions
118Shares Held
11.8MCall Options Held
2.7KPut Options Held
5K-
Trigran Investments, Inc.2.14MShares$52.4 Million5.66% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$39.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA790KShares$19.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX749KShares$18.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny598KShares$14.7 Million0.03% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $358M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...